Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,251 across all filing types
Latest filing 2020-05-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
关于延期回复《关于对公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易预案信息披露的问询函》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about a major asset swap, share issuance, cash purchase of assets, and related-party transaction plan. It discusses the appointment and change of auditing firms related to the major asset restructuring and the company's communication with regulatory authorities. The document does not contain actual financial statements or detailed financial data but rather updates on regulatory correspondence, audit firm appointments, and procedural matters. The document length is short (1738 characters) and is primarily an announcement of ongoing regulatory and procedural developments rather than a full report or financial disclosure. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-05-19 Chinese
第七届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 15th meeting of the 7th Board of Directors of Jiangxi Changjiu Biochemical Co., Ltd. It details the election of a new chairman and the appointment of a new general manager, including voting results and biographical information of the appointees. It also mentions the approval of a proposal related to the appointment of intermediaries for a major asset restructuring. The document is a board meeting resolution announcement, focusing on changes in the company's board and senior management. It is not a full annual report, audit report, or financial statement, nor is it a regulatory filing or a report publication announcement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 1931 characters, which is consistent with a typical board resolution announcement rather than a full report.
2020-05-19 Chinese
独立董事关于第七届董事会第十五次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on proposals discussed at the 15th meeting of the 7th board of directors of Jiangxi Changjiu Bio-chemical Co., Ltd. It includes opinions on the appointment of the general manager and the hiring of intermediaries for a major asset restructuring. The document is a formal statement related to board/management decisions rather than a full report or announcement of financial results. It does not contain financial data or detailed financial analysis, nor is it a regulatory filing or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related opinions.
2020-05-19 Chinese
关于董事长、总经理职务调整的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's board of directors and senior management positions, specifically the resignation and appointment of the chairman and general manager. It includes details about the individuals involved and their qualifications. There is no financial data, report, or regulatory filing referenced. The content fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming the classification.
2020-05-19 Chinese
关于重大资产重组拟聘会计师事务所事项的公告
Audit Report / Information Classification · 95% confidence The document is an announcement by Jiangxi Changjiu Biochemical Co., Ltd. regarding the proposed appointment of accounting firms for a major asset restructuring. It details the background, reasons for changing the originally intended auditor (PwC), and the new proposed auditors (Shanghui and Zhongxingcai). It includes information about the firms' qualifications, personnel, independence, and the procedural steps taken by the company's board and audit committee. The document is a formal announcement about the appointment of auditors related to a significant corporate transaction, not the audit report itself or the full asset restructuring report. It does not contain financial statements or audit results but focuses on the appointment process and related disclosures. Therefore, it fits best under the category of Audit Report / Information (AR), as it relates to audit matters and auditor appointment for a major asset restructuring, but is not a full annual report or interim report. FY 2020
2020-05-19 Chinese
独立董事关于第七届董事会第十五次会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing prior approval opinions on a board meeting agenda item related to the appointment of an accounting firm for a major asset restructuring. It references regulatory rules and company bylaws but does not contain financial statements, audit results, or detailed financial data. The document is short (578 characters) and serves as an official opinion or endorsement rather than a full report or announcement of voting results. It is not a full audit report, annual report, or management report. It is also not a regulatory filing or announcement of a report publication. The content fits best under Board/Management Information (MANG) as it relates to board-level decisions and approvals regarding management matters.
2020-05-19 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.